News Focus
News Focus
icon url

SC8

11/26/24 7:25 AM

#182191 RE: konshe #182188

Why would anyone pay $10 a share after dilution for a public domain tech anybody is free to copy? All the original Radiogel patents have expired and at least one competitor beat RDGL to human trials.